Stock Scorecard



Stock Summary for Pfizer Inc (PFE) - $28.06 as of 11/18/2026 8:48:37 PM EST

Total Score

7 out of 30

Safety Score

44 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PFE

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PFE

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PFE

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PFE

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PFE (44 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 8
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for PFE

Should Vaccine Medium Launch Require Action From Thermo Fisher Scientific (TMO) Investors? 11/18/2026 11:20:00 PM
Amgen Inc Stock (AMGN) Moved Down by 3.21% on Nov 18: What Signal Does It Send? 11/18/2026 7:15:00 PM
C4 Therapeutics' Andrew Hirsch bets a microgram-dose degrader can beat CAR-T durability in myeloma 11/18/2026 6:52:00 PM
Merck & Co Inc Stock (MRK) Moved Down by 3.35% on Nov 18: Facts Behind the Movement 11/18/2026 6:15:00 PM
Pfizer Pays $330 Million Upfront for Starna's In Vivo CAR-T Programs in $2.6 Billion Deal 11/18/2026 5:05:00 PM
Pfizer leaps into ‘in vivo’ CAR-T with latest China deal 11/18/2026 4:08:00 PM
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s 11/18/2026 4:05:00 PM
Pfizer Strikes Multibillion-Dollar Deal to Take on Autoimmune Diseases 11/18/2026 3:53:00 PM
Pfizer Licenses In Vivo CAR T Therapies From Starna Therapeutics in $2.6B Deal 11/18/2026 3:33:00 PM
Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Advance Adenovirus Vaccine Production 11/18/2026 1:10:00 PM

Financial Details for PFE

Company Overview

Ticker PFE
Company Name Pfizer Inc
Country N/A
Description Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - GENERAL
Most Recent Quarter 9/30/2026
Next Earnings Date 2/2/2027

Stock Price History

Last Day Price 28.06
Price 4 Years Ago 40.33
Last Day Price Updated 11/18/2026 8:48:37 PM EST
Last Day Volume 37,222,570
Average Daily Volume 33,483,914
52-Week High 30.99
52-Week Low 22.76
Last Price to 52 Week Low 23.29%

Valuation Measures

Trailing PE N/A
Industry PE 46.20
Sector PE 60.89
5-Year Average PE 9.10
Free Cash Flow Ratio 87.69
Industry Free Cash Flow Ratio 26.18
Sector Free Cash Flow Ratio 27.16
Current Ratio Most Recent Quarter 1.42
Total Cash Per Share 0.32
Book Value Per Share Most Recent Quarter 15.61
Price to Book Ratio 1.89
Industry Price to Book Ratio 10.57
Sector Price to Book Ratio 26.87
Price to Sales Ratio Twelve Trailing Months 2.58
Industry Price to Sales Ratio Twelve Trailing Months 4.16
Sector Price to Sales Ratio Twelve Trailing Months 19.65
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 5,699,854,000
Market Capitalization 159,937,903,240
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/6/2026
Previous Dividend Amount 0.4300
Current Dividend Amount 0.4300
Total Years Dividend Increasing Dividend Contender - Increasing for 15 Years
Trailing Annual Dividend Rate 1.72
Trailing Annual Dividend Yield 5.97%
Forward Annual Dividend Rate 1.72
Forward Annual Dividend Yield 5.97%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 7.31%
5-Year Average Dividend Yield 6.38%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 1.18%
5-Year Dividend Growth Rate Percentage 1.82%
All-Time Dividend Growth Rate Percentage 8.40%
Dividend Payout Ratio 245.71%

Income Statement

Quarterly Earnings Growth YOY -9.70%
Annual Earnings Growth -3.24%
Reported EPS 12 Trailing Months 0.70
Reported EPS Past Year 2.39
Reported EPS Prior Year 3.23
Net Income Twelve Trailing Months 4,033,000,000
Net Income Past Year 7,771,000,000
Net Income Prior Year 8,031,000,000
Quarterly Revenue Growth YOY -0.40%
5-Year Revenue Growth 8.48%
Operating Margin Twelve Trailing Months 29.10%

Balance Sheet

Total Cash Most Recent Quarter 1,824,000,000
Total Cash Past Year 1,142,000,000
Total Cash Prior Year 1,043,000,000
Net Cash Position Most Recent Quarter -58,173,000,000
Net Cash Position Past Year -59,665,000,000
Long Term Debt Past Year 60,807,000,000
Long Term Debt Prior Year 56,703,000,000
Total Debt Most Recent Quarter 59,997,000,000
Equity to Debt Ratio Past Year 0.59
Equity to Debt Ratio Most Recent Quarter 0.60
Total Stockholder Equity Past Year 86,476,000,000
Total Stockholder Equity Prior Year 88,203,000,000
Total Stockholder Equity Most Recent Quarter 89,001,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 11,787,000,000
Free Cash Flow Per Share Twelve Trailing Months 2.07
Free Cash Flow Past Year 9,076,000,000
Free Cash Flow Prior Year 9,835,000,000

Options

Put/Call Ratio 1.79
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.30
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 11/17/2026 5:52:48 AM EST